Thus, ML213 and probably other Kv7.4 and Kv7.5 selective activators may be useful for preventing or reducing coronary spasm (angina pectoris episodes) in the patients presenting with elevated plasma histamine concentrations due to mast cell atheroma infiltration or during acute allergic reaction associated with plasma histamine surges. Here, KCNQ4 is linked to angina pectoris.